2017 Society for Translational Oncology Fellows’ Forum (STOFF) | Society for Translational Oncology (STO)

2017 STO Fellows’ Forum (STOFF)

October 12-15, 2017
Lansdowne in Leesburg, VA
2017 STOFF Agenda (PDF)

Scholars' Presentation Summaries

Topic: Personalized Cancer Treatment
Bruce A. Chabner, MD
Summary (PDF)

Topic: Issues in Design of Translational Research Trials
Susan Hilsenbeck, PhD
Summary (PDF)

Topics: IRB Issues and Translational Research
PI Responsibilities and Conflict of Interest
Stacey Berg, MD
Summary 1 (PDF) | Summary 2 (PDF)

Topic: CAR T Cell Therapies for Myeloma
Eric Smith, MD, PhD
Summary (PDF)

Topics: Phase 1 Clinical Trials: Hypothesis Testing
How to Write a Grant
Keith Flaherty, MD
Summary 1 (PDF) | Summary 2 (PDF)

Topic: Lessons From Translational Research in Myeloid Leukemia
Ross Levine, MD
Summary (PDF)

Topics: Cancer Drug Development: Views from Industry and Academia
Introduction to Drug Development
Bernardo Goulart, MD, MS
Summary (PDF)

Topic: The Cost and Value of Cancer MedicineThomas G. Roberts, Jr., MD, MSoc Sci
Summary (PDF)

Topic: The Cancer Genome Atlas (TCGA)William Kim, MD
Summary (PDF)

Topic: Guidelines for Good Basic ResearchMark W. Duncan, PhD
Summary (PDF)

Topic: Immune Checkpoint Inhibition in Advanced CancerMichael Postow, MD
Summary(PDF)

Topic: PharmacogenomicsPeter H. O’Donnell, MD
Summary (PDF)

Topic: Oncology Drug Development: A Regulatory PerspectiveTatiana Prowell, MD
Summaries (PDF)

Acknowledgments

The Society for Translational Oncology gratefully acknowledges educational grants in partial support of this activity from:

Amgen
EcoR1 Capital
Takeda Oncology
Pfizer
CHAAO

Distinguished Faculty

Founded by Dr. Bruce A. Chabner (Massachusetts General Hospital/Harvard Medical School) over two decades ago, the 2018 Fellows’ Forum was co-chaired by Dr. Keith Flaherty (Massachusetts General Hospital/Harvard Medical School), Dr. Stacey Berg (Baylor College of Medicine/Texas Children’s Cancer Center) and Dr. Ross Levine (Memorial Sloan Kettering Cancer Center).

The distinguished STOFF faculty includes researchers and educators from the National Cancer Institute (NCI), the U.S. Food and Drug Administration (FDA), and leading U.S. cancer centers. The workshop has received national recognition for its focused and practical approach to preparing oncologists to conduct cancer drug research. Alumni total more than 400.

STOFF 2018

STOFF 2017

STOFF 2016

STOFF 2015